Business Description
Acutus Medical Inc
NAICS : 325413
SIC : 3845
2210 Faraday Avenue, Suite 100, Carlsbad, CA, USA, 92008
Description
Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Europe.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.63 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.67 | |||||
| Debt-to-EBITDA | -0.4 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -7.25 | |||||
| Beneish M-Score | -3.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 67.1 | |||||
| 3-Year EBITDA Growth Rate | -15.1 | |||||
| 3-Year EPS without NRI Growth Rate | -13.1 | |||||
| 3-Year FCF Growth Rate | -21.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 24.73 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.76 | |||||
| 9-Day RSI | 59.89 | |||||
| 14-Day RSI | 60.92 | |||||
| 6-1 Month Momentum % | -61.76 | |||||
| 12-1 Month Momentum % | -94.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.03 | |||||
| Quick Ratio | 5.01 | |||||
| Cash Ratio | 4.31 | |||||
| Days Inventory | 171.88 | |||||
| Days Sales Outstanding | 69.99 | |||||
| Days Payable | 67.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.4 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -89.66 | |||||
| Operating Margin % | -648.48 | |||||
| Net Margin % | -740.62 | |||||
| ROE % | -132.69 | |||||
| ROA % | -80.18 | |||||
| ROIC % | -201.5 | |||||
| ROC (Joel Greenblatt) % | -488.05 | |||||
| ROCE % | -86.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.5 | |||||
| PB Ratio | 0.63 | |||||
| Price-to-Tangible-Book | 0.67 | |||||
| EV-to-EBIT | -0.12 | |||||
| EV-to-EBITDA | -0.12 | |||||
| EV-to-Revenue | 0.79 | |||||
| EV-to-Forward-Revenue | 0.89 | |||||
| EV-to-FCF | -0.14 | |||||
| Price-to-Net-Current-Asset-Value | 1.03 | |||||
| Price-to-Net-Cash | 3.68 | |||||
| Earnings Yield (Greenblatt) % | -869.55 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:AFIB
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 17.353 | ||
| EPS (TTM) ($) | -4.5 | ||
| Beta | 0 | ||
| Volatility % | 117.64 | ||
| 14-Day RSI | 60.92 | ||
| 14-Day ATR ($) | 0.15604 | ||
| 20-Day SMA ($) | 1.3825 | ||
| 12-1 Month Momentum % | -94.19 | ||
| 52-Week Range ($) | 0.48 - 14.99 | ||
| Shares Outstanding (Mil) | 28.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Acutus Medical Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||